Veradermics reports positive Phase 2/3 trial results for hair loss drug
Tweet Send to a Friend
Veradermics Inc. (NYSE: MANE) announced that its oral hair loss treatment VDPHL01 met all primary and secondary endpoints in a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


